• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.县级阿片类药物配给率对个体处方类阿片和海洛因消费模式的影响:来自美国全国数据的证据。
Am J Psychiatry. 2022 Apr;179(4):305-311. doi: 10.1176/appi.ajp.2021.21060602. Epub 2021 Dec 8.
2
National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health.滥用处方类阿片和使用海洛因人群的全国多药使用模式。来自全国毒品使用与健康调查的家庭调查结果。
Drug Alcohol Depend. 2022 Sep 1;238:109553. doi: 10.1016/j.drugalcdep.2022.109553. Epub 2022 Jul 6.
3
Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.2015-2020 年美国处方兴奋剂和阿片类药物使用与非法使用之间的关联。
J Subst Abuse Treat. 2022 Dec;143:108894. doi: 10.1016/j.jsat.2022.108894. Epub 2022 Sep 30.
4
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.处方药物监测项目的运行特征与致命海洛因中毒。
Int J Drug Policy. 2019 Dec;74:174-180. doi: 10.1016/j.drugpo.2019.10.001. Epub 2019 Oct 15.
5
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
6
Do naloxone access laws affect perceived risk of heroin use? Evidence from national US data.纳洛酮获取法是否会影响人们对海洛因使用的风险感知?来自美国全国数据的证据。
Addiction. 2022 Mar;117(3):666-676. doi: 10.1111/add.15682. Epub 2021 Oct 6.
7
Overestimation of Prescription Pain Reliever Misuse and Heroin Use among Adults.成年人处方止痛药滥用和海洛因使用的高估。
Subst Use Misuse. 2021;56(4):552-558. doi: 10.1080/10826084.2021.1887255. Epub 2021 Feb 24.
8
Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?处方药监测项目会助长处方类或非法类阿片类药物的滥用吗?
Subst Abus. 2021;42(1):65-75. doi: 10.1080/08897077.2019.1695707. Epub 2019 Dec 10.
9
Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.2005 - 2016年阿片类药物治疗项目参与者中使用海洛因及非医疗用途处方阿片类药物的流行趋势的种族/民族差异
Subst Use Misuse. 2018 Jan 28;53(2):290-300. doi: 10.1080/10826084.2017.1334070. Epub 2017 Aug 30.
10
Factors associated with heroin use among those reporting -prescription opioid misuse: Results from a nationally -representative sample.报告处方类阿片药物滥用者中与海洛因使用相关的因素:一项全国代表性样本的研究结果。
J Opioid Manag. 2022 May-Jun;18(3):243-255. doi: 10.5055/jom.2022.0716.

引用本文的文献

1
Causation and Common Liability in the Progression of the U.S. Opioid Crisis.美国阿片类药物危机演变中的因果关系与共同责任
J Stud Alcohol Drugs. 2024 Jan;85(1):12-18. doi: 10.15288/jsad.23-00289. Epub 2023 Dec 11.
2
Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: application of the PRECEDE-PROCEED model-cross-sectional analysis.与三州阿巴拉契亚县阿片类药物成瘾者帮助行为相关的倾向因素、促成因素和强化因素:PRECEDE-PROCEED 模型的应用——横断面分析。
BMJ Open. 2023 May 16;13(5):e066147. doi: 10.1136/bmjopen-2022-066147.

本文引用的文献

1
Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use.强有力的处方监测计划与长期阿片类药物使用的突然中断。
Am J Prev Med. 2021 Oct;61(4):537-544. doi: 10.1016/j.amepre.2021.04.019. Epub 2021 Jul 4.
2
State pain management clinic policies and county opioid prescribing: A fixed effects analysis.州疼痛管理诊所政策与县阿片类药物处方:固定效应分析。
Drug Alcohol Depend. 2020 Nov 1;216:108239. doi: 10.1016/j.drugalcdep.2020.108239. Epub 2020 Aug 18.
3
The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.处方药物监测项目在减少阿片类药物相关危害和后果方面的有效性:系统评价。
BMC Health Serv Res. 2019 Nov 1;19(1):784. doi: 10.1186/s12913-019-4642-8.
4
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.三重波流行疫情:美国阿片类药物过量危机的供需驱动因素。
Int J Drug Policy. 2019 Sep;71:183-188. doi: 10.1016/j.drugpo.2019.01.010. Epub 2019 Feb 2.
5
Opioid prescribing decreases after learning of a patient's fatal overdose.在了解到患者致命过量用药后,阿片类药物的处方量会减少。
Science. 2018 Aug 10;361(6402):588-590. doi: 10.1126/science.aat4595.
6
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.2011-2015 年马萨诸塞州潜在不适当阿片类药物处方、用药过量和死亡率。
J Gen Intern Med. 2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14.
7
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review.处方药物监测项目与非致命性和致命性药物过量之间的关联:一项系统性综述。
Ann Intern Med. 2018 Jun 5;168(11):783-790. doi: 10.7326/M17-3074. Epub 2018 May 8.
8
Potential Impact of Medical Marijuana on Nonmedical Opioid Use.医用大麻对非医用阿片类药物使用的潜在影响。
Am J Psychiatry. 2018 Mar 1;175(3):284. doi: 10.1176/appi.ajp.2017.17101149.
9
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.美国成年人的处方阿片类药物使用、滥用和使用障碍:2015 年全国毒品使用与健康调查。
Ann Intern Med. 2017 Sep 5;167(5):293-301. doi: 10.7326/M17-0865. Epub 2017 Aug 1.
10
New Data on Opioid Use and Prescribing in the United States.美国阿片类药物使用与处方的新数据。
JAMA. 2017 Aug 1;318(5):425-426. doi: 10.1001/jama.2017.8913.

县级阿片类药物配给率对个体处方类阿片和海洛因消费模式的影响:来自美国全国数据的证据。

Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.

机构信息

Department of Sociology, Ohio State University, Columbus (Vuolo); Department of Sociology, Purdue University, West Lafayette, Ind. (Kelly).

出版信息

Am J Psychiatry. 2022 Apr;179(4):305-311. doi: 10.1176/appi.ajp.2021.21060602. Epub 2021 Dec 8.

DOI:10.1176/appi.ajp.2021.21060602
PMID:34875874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8976704/
Abstract

OBJECTIVE

The authors examined directly whether county-level changes in opioid dispensing rates affect individual-level prescription opioid misuse, frequency of use, and dependence, as well as the same outcomes for heroin.

METHODS

Using data from the restricted-access National Survey on Drug Use and Health, the Centers for Disease Control and Prevention's retail opioid prescription database, the Prescription Drug Abuse Policy System, and the U.S. Census, the authors applied fixed-effects models to determine whether county-level dispensing rates affected prescription opioid outcomes as intended and whether changes in rates adversely affected heroin use outcomes. Bayes factors were used to confirm evidence for null findings.

RESULTS

The sample included 748,800 respondents age 12 and older from 2006 to 2016. The odds of prescription opioid misuse, increased frequency of misuse, and dependence were 7.2%, 3.5%, and 10.4% higher, respectively, per standard deviation increase in the county-level opioid dispensing rate per 100 persons. There was no evidence for any association between opioid dispensing rates and the three heroin outcomes. The odds ratio was nonsignificant according to frequentist techniques in fixed-effects models, and Bayesian techniques confirmed very strong support for the null hypothesis.

CONCLUSIONS

County-level opioid dispensing rates are directly associated with individual-level prescription opioid misuse, frequency of misuse, and dependence. Changes in dispensing were not associated with population shifts in heroin use. Reductions in opioid dispensing rates have contributed to stemming prior increases in prescription opioid misuse while not adversely affecting heroin use. Physicians and other health care providers can take action to minimize opioid dispensing for tangible benefits regarding prescription opioid misuse without adverse effects on heroin use.

摘要

目的

作者直接检验了县级处方类阿片类药物配给率的变化是否会影响个体层面的处方类阿片类药物滥用、使用频率和依赖,以及海洛因的同样结果。

方法

作者使用受限访问的国家药物使用和健康调查、疾病控制和预防中心的零售类阿片类药物处方数据库、处方药物滥用政策系统和美国人口普查的数据,应用固定效应模型来确定县级配给率是否按预期影响处方类阿片类药物的结果,以及配给率的变化是否对海洛因使用结果产生不利影响。贝叶斯因子用于确认无效发现的证据。

结果

样本包括 2006 年至 2016 年间年龄在 12 岁及以上的 748800 名受访者。每增加 100 人县级阿片类药物配给率标准偏差,处方类阿片类药物滥用、滥用频率增加和依赖的几率分别高出 7.2%、3.5%和 10.4%。没有证据表明阿片类药物配给率与三种海洛因结果之间存在任何关联。根据固定效应模型中的频繁技术,比值比无统计学意义,贝叶斯技术则强烈支持无效假设。

结论

县级阿片类药物配给率与个体层面的处方类阿片类药物滥用、滥用频率和依赖直接相关。配给的变化与海洛因使用的人口转移无关。减少阿片类药物配给率有助于遏制先前处方类阿片类药物滥用的增加,而不会对海洛因使用产生不利影响。医生和其他卫生保健提供者可以采取行动,减少阿片类药物的配给,以减少处方类阿片类药物滥用的明显好处,而不会对海洛因使用产生不利影响。